Wells Fargo
MDCX

Wells Fargo’s Medicus Pharma MDCX Stock Holding History

Wells Fargo’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89 Buy
200
+125
+167% +$44 ﹤0.01% 6655
2026
Q1 		$34 Hold
75
– – ﹤0.01% 6679
2025
Q4 		$115 Hold
75
– – ﹤0.01% 6418
2025
Q3 		$174 Hold
75
– – ﹤0.01% 6353
2025
Q2 		$224 Buy
+75
New +$300 ﹤0.01% 6436

Other funds holding MDCX

ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return

Wells Fargo's MDCX Position: Q2 2026 in Review

Wells Fargo increased its Medicus Pharma (MDCX) stake by 167% in Q2 2026, buying an estimated $44 and bringing the position to 200 shares worth $89. The position accounts for ﹤0.01% of the portfolio, ranked #6655.

Wells Fargo first reported a position in MDCX in Q2 2025 and has held it in 5 quarters since. The position peaked at $224 in Q2 2025. 23 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

  • Wells Fargo held 200 shares of Medicus Pharma worth $89 as of Q2 2026.
  • Wells Fargo bought 125 Medicus Pharma shares in Q2 2026, an estimated $44.
  • Medicus Pharma made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6655 holding.
  • Wells Fargo first reported a position in Medicus Pharma in Q2 2025 and has held it in 5 quarters since.
  • Wells Fargo's Medicus Pharma position peaked at $224 in Q2 2025.
  • 23 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.